Inventor

FERRER MONTIEL ANTONIO

ES18 patents

⚠️ This page may combine multiple inventors who share the name “FERRER MONTIEL ANTONIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FERRER MONTIEL ANTONIO

LUBRIZOL ADVANCED MAT INC

Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes

Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes

Cosmetic composition containing halomonas ferment extract, and use thereof

UNIV MIGUEL HERNANDEZ DE ELCHE

Methods for treating occular irritation involving tearing by administering modulators of TRPM8

Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor agonists

GARCIA SANZ NURIA

Peptide-based compounds and compositions which inhibit muscle contraction

Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp

CARREÑO SERRAÏMA CRISTINA

Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails

Neuronal exocytosis inhibiting peptides

AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A

Peptides for inhibiting cholinergic calcitonin gene-related peptide (CGRP) and acetylcholine (ACH) release or inhibiting sensitization-mediated by TRPV1-mediated excitability in sensory neurons and methods of use thereof

Peptides having inhibitory activity on muscarinic receptor M3

UNIV CALIFORNIA

Chemically-modified clostridiatoxin with improved properties

SERRAÏMA CRISTINA CARREÑO

Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions

CEBRIAN PUCHE JUAN

Pigmentation-regulating compounds

BELMONTE MARTNEZ CARLOS

Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia

(unassigned)

N-methyl-d-aspartate receptor channel blockers and method for identifying such

BCN PEPTIDES SA

Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis

UNIV MIGUEL HERNÁNDEZ DE ELCHE

Use of TRMP8 for treating opthalmic diseases or conditions involving tearing